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Regulated degradation of cytoplasmic mRNA is important for the accurate execution of 
gene expression programmes in eukaryotic cells. A key step in this process is the 
shortening and removal of the mRNA poly(A) tail, which can be achieved by the 
recruitment of the multi-subunit Ccr4-Not nuclease complex via sequence-specific RNA 
binding proteins or the microRNA machinery. The Ccr4-Not complex contains several 
modules that are attached to its large subunit CNOT1. Modules include the nuclease 
module, which associates with the MIF4G domain of CNOT1 and contains the catalytic 
subunits Caf1 and Ccr4, as well as the module containing the non-catalytic CNOT9 
subunit, which binds to the DUF3819 domain of CNOT1. To understand the contributions 
of the individual modules to the activity of the complex, we have started to reconstitute 
sub-complexes of the human Ccr4-Not complex containing one or several functional 
modules. Here, we report the reconstitution of a pentameric complex including a BTG2-
Caf1-Ccr4 nuclease module, CNOT9 and the central region of CNOT1 encompassing the 
MIF4G and DUF3819 domains. By comparing the biochemical activities of the pentameric 
complex and the nuclease module, we conclude that the CNOT1-CNOT9 components 
stimulate deadenylation by the nuclease module. In addition, we show that a pentameric 
complex containing the melanoma-associated CNOT9 P131L variant is able to support 








Regulated degradation of cytoplasmic mRNA is essential for the control of gene 
expression programmes in eukaryotic cells [1-3]. Control of mRNA decay typically 
involves the recognition of sequence elements in the 3’ untranslated region of mRNAs by 
RNA-binding proteins or miRNA-mediated repression complexes, which recruit 
components of the RNA-degradation machinery [4-6]. Decay is initiated by shortening 
and removal of the poly(A) tail via the enzymatic action of the Ccr4-Not and Pan2-Pan3 
deadenylases. Subsequently, the 5’ cap structure of the mRNA is removed, followed by 
5’-3’ degradation by the exonuclease Xrn1 or 3’-5’ degradation by the exosome complex 
[1-3, 5]. In recent years, an expanding number of RNA-binding factors have been 
identified that specifically interact with the Ccr4-Not complex, which appears to be a 
focal point of regulated mRNA degradation. Examples include the PUF proteins [7], 
Nanos [8, 9] and Tristetraprolin (TTP; zinc-finger protein ZFP36) [10-12], which are 
sequence-specific RNA-binding proteins; Roquin, which binds to a stem-loop structural 
element [13, 14]; and GW182 (TNRC6), which is a core component of the miRNA-
repression complex [15, 16].  
 
Ccr4-Not is a large multi-subunit complex composed of eight subunits with the large 
subunit CNOT1 acting as a scaffold for different functional modules [6, 17]. The N-
terminal domain is bound by CNOT10 and CNOT11 [18, 19], while the C-terminal region 
forms the NOT module with the CNOT2 and CNOT3 subunits [20, 21]. The central region 
of CNOT1 encompasses two domains. The MIF4G domain mediates interactions with the 
two catalytic subunits of the complex: Caf1, a DEDDh-type ribonuclease, and Ccr4, 
which contains an EEP (Endonuclease-Exonuclease-Phosphatase) domain [22, 23]. The 
contribution of each of the catalytic subunits to the activity of the Ccr4-Not complex 
appears to differ in various organisms. In the yeast Saccharomyces cerevisiae, the active 
site of Caf1 contains non-conserved amino acids at key positions and its activity is not 
required for its in vivo function [24]. By contrast, the Caf1 and Ccr4 subunits both 
contribute to the activity of the purified Schizosaccharomyces pombe complex or the 
Drosophila melanogaster nuclease module [25, 26]. Interestingly, the activities of Caf1 
and Ccr4 are both required for the activity of the human nuclease module and 
inactivating mutations in the active site of either Caf1 or Ccr4 abolish all activity of the 
nuclease module [27]. Adjacent to the MIF4G domain is the DUF3819 domain (domain of 
unknown function 3819), which provides a platform for CNOT9 (RQCD1/Caf40) [15, 16]. 
The latter can mediate interactions with RNA-binding factors, including the miRNA-
associated protein GW182 [15, 16], the ARE (A/U rich element) binding protein TTP 
[11], and the stem-loop binding protein Roquin [13]. A recurrent mutation in CNOT9 
resulting in amino acid change P131L is found in a sub-set of melanoma tumours, but 
the impact of this amino acid substitution on the structure and function of CNOT9 is 
currently unknown [28]. 
 
It is unclear whether the non-catalytic subunits have roles other than mediating protein-
protein interactions with RNA-binding regulatory factors. It has been reported that an 
intact recombinant S. pombe Ccr4-Not complex has greater deadenylase activity than 
the isolated nuclease module, but it is not known which components contribute to the 
stimulation of the nuclease subunits [26]. To begin to address this question, we aimed to 
reconstitute functional Ccr4-Not sub-complexes containing one or several functional 
modules. To this end, we recently reported the initial reconstitution of a trimeric 
nuclease sub-complex composed of human BTG2-Caf1-Ccr4 [27]. To extend this 
approach and begin to evaluate the contribution of the non-catalytic subunits of Ccr4-
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Not to deadenylation, we aimed to expand the nuclease module by including the central 
region of CNOT1 encompassing the MIF4G and DUF3819 domains as well as the CNOT9 
subunit. Analysis of the deadenylase activities of this pentameric sub-complex, which we 
termed the central module, revealed a role for the non-catalytic subunits in stimulating 
the enzymatic activity of the nuclease module. In addition, we show that the central 
module containing the melanoma-associated CNOT9 P131L variant is able to support 




Expression and purification of Caf1 and the BTG2-Caf1 dimer 
The monomeric human Caf1/CNOT7 enzyme was expressed and purified from 
Escherichia coli BL21 (DE3) using expression plasmid pQE80L-CNOT7 as described 
before [29]. The catalytically inactive version containing the amino acid substitution 
D40A was also expressed and purified as described before [29]. 
The BTG2-Caf1/CNOT7 dimer was expressed and purified as described before [27], 
except that a vector for dual expression of BTG2 and Caf1 was used. Plasmid pACYC-
Duet1-BTG2/CNOT7 was generated for dual expression of His-BTG2 and Caf1/CNOT7. 
Briefly, a codon-optimised CNOT7 cDNA (digested with 5’ BamHI and 3’ SalI) was 
inserted in the BglII and XhoI restriction sites of multiple cloning site 2 of vector pACYC-
Duet1 (Merck). Then, the human BTG2 cDNA was inserted into multiple cloning site 1 
using the BamHI and HindIII restriction sites. The BTG2-Caf1 dimer was subsequently 
expressed and purified as described before [27]. Purified proteins were stored in small 
aliquots at -80°C. Protein concentrations were determined using the Protein Assay 
Reagent (Bio-Rad). 
 
Expression and purification of the trimeric BTG2-Caf1-Ccr4 nuclease module 
The trimeric BTG2-Caf1-Ccr4 complex was purified using a modified two-step procedure 
by co-expression of BTG2, Strep-Ccr4/CNOT6L, and Caf1/CNOT7 [27].  
Plasmid pACYC-Duet1-Strep-CNOT6L/CNOT7 for dual expression of Strep-tagged 
CNOT6L and CNOT7 was generated in two stages. First, the pQE80L expression vector 
(Qiagen) was modified by replacing the His-tag coding sequences with Strep-tag coding 
sequences by inserting a synthetic duplex formed by oligonucleotides 5’- AATTCA-
TTAAAGAGGAGAAATTAACTATGGCTAGCTGGAGCCACCCGCAGTTCGAGAAAGGTGGAGGTT-
CCGGAGGTGGATCGGGAGGTGGATCGTGGAGCCACCCGCAGTTCGAAAAAG -3’ and 5’-GAT-
CCTTTTTCGAACTGCGGGTGGCTCCACGATCCACCTCCCGATCCACCTCCGGAACCTCCACCTT-
TCTCGAACTGCGG-GTGGCTCCAGCTAGCCATAGTTAATTTCTCCTCTTTAATG-3’ into the 5’ 
EcoRI and 3’ BamHI restriction sites of pQE80L. Then, a codon-optimised CNOT6L cDNA 
was inserted into the 5’ BamHI and 3’ SalI restriction sites. After amplification of the 
Strep-CNOT6L cDNA using oligonucleotides 5’-AAAAACCATGGCTAGCTGGAGCCAC-3’ and 
5’- GTTCTGAGGTCATTACTGG-3’, the Strep-CNOT6L cDNA was inserted into the NcoI and 
SalI sites of multiple cloning site 1 of pACYC-Duet1 (Merck) containing a BamHI/SalI 
CNOT7 cDNA fragment inserted in the BglII/XhoI sites of multiple cloning site 2.  
After transformation of E. coli strain BL21 (DE3) with plasmids pQE80L-BTG2 and 
pACYCDuet-1/Strep-CNOT6L/CNOT7, protein expression (1 L LB medium) was induced 
at OD600 0.7-0.8 by the addition of isopropyl β-D-1-thiogalactopyranoside (IPTG; 0.2 mM 
final concentration) for 16 h at 18°C. Cell pellets were resuspended in 0.003 vol buffer 
SA (20 mM Tris-HCl pH 7.8, 250 mM NaCl, 10% glycerol, 2 mM β-mercaptoethanol), 
lysed by sonication (five cycles; 30 sec on/30 sec off; 60% amplitude, Qsonica XL2000), 
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and cleared by centrifugation (16,000×g for 45 min at 4C).The soluble fraction was 
applied onto a 1 ml Strep-Tactin sepharose gravity column (IBA Life Sciences) and 
eluted with buffer SB (20 mM Tris-HCl pH 7.8, 250 mM NaCl, 10% glycerol, 1 mM β-
mercaptoethanol, 10 mM D-Desthiobiotin) to isolate trimeric His•BTG2-Caf1-Strep•Ccr4 
complexes. After collection of peak fractions, proteins were further purified by size-
exclusion chromatography using a HiPrep 16/60 Sephacryl S-200 HR column (GE 
Healthcare) equilibrated and eluted in buffer GF (50 mM Tris-HCl pH 7.9, 250 mM NaCl, 
5% glycerol, 1 mM β-mercaptoethanol). Peak fractions were pooled and concentrated 
using a Vivaspin concentrator (Sartorius). The inactive version containing amino acid 
substitutions D40A of Caf1 and E240A of Ccr4 was expressed and purified using the 
same procedure. Protein concentrations were determined using the Protein Assay 
Reagent (Bio-Rad) and purified proteins were stored in small aliquots at -80°C.  
 
Expression and purification of the pentameric central module 
To isolate the pentameric central module composed of BTG2-Caf1-Ccr4-CNOT1-CNOT9, 
the trimeric nuclease and CNOT1-CNOT9 modules were first expressed in E. coli BL21 
(DE3) and purified separately.  
The nuclease module was expressed and purified as described above. The CNOT1-CNOT9 
dimer was obtained by co-expression of both proteins using plasmid pACYC-Duet1-
CNOT1/CNOT9. This plasmid contained a codon-optimised cDNA encoding the MIF4G and 
DUF3819 domains of CNOT1 (amino acids 1093-1595) in multiple cloning site 1 and a 
human cDNA encoding the CNOT9 (ARM domain; amino acids 33-283) in multiple cloning 
site 2. Both cDNA fragments contained a 5’ BamHI and a 3’ SalI site, and were inserted 
into the corresponding sites of multiple cloning site 1 (CNOT1) or the 5’ BglII and 3’ XhoI 
sites of multiple cloning site 2 (CNOT9).  
To purify the CNOT1-CNOT9 dimer, cells (1 L LB medium) were grown to OD600 0.7-0.8. 
After addition of IPTG (final concentration 0.2 mM), cultures were incubated for 16 h at 
18°C and cells were harvested by centrifugation. The cell pellet was resuspended in 5 mL 
buffer HA (20 mM Tris-HCl pH 7.9, 250 mM NaCl, 1 mM β-mercaptoethanol, 5% glycerol 
and 20 mM imidazole) per litre of culture, lysed by sonication and the soluble lysate was 
isolated by centrifugation. The soluble lysate was then loaded onto a HisTrap FF pre-
packed column (GE) equilibrated with buffer HA (20 mM Tris-HCl pH 7.9, 250 mM NaCl, 
1 mM β-mercaptoethanol, 5% glycerol and 20 mM imidazole). After washing the 
unbound fraction, bound proteins were eluted using buffer HB (as buffer HA, but 
containing 250 mM imidazole) in 1 mL fractions.  
The purified nuclease and CNOT1-CNOT9 dimer were then combined (molar ratio 
nuclease module:CNOT1-CNOT9 dimer = 1:1.2) and incubated for 16 h at 4C to allow 
binding. Then, buffer was exchanged using a PD-10 column (GE) to buffer SA to remove 
D-desthiobiotin. After buffer exchange, the sample was loaded on a Poly-Prep gravity-
flow column (Bio-Rad) packed with Strep-Tactin sepharose (IBA) and equilibrated with 
buffer SA (20 mM Tris-HCl pH 7.9, 250 mM NaCl, 1 mM β-mercaptoethanol and 5% 
glycerol). After washing the unbound fraction, the column was eluted using buffer SB. 
After exchanging the buffer composition to buffer SA using PD-10 columns (GE 
Healthcare), protein concentrations were determined using the Protein Assay Reagent 
(Bio-Rad). If necessary, protein samples were concentrated using Vivaspin spin columns 
(Sartorius). Purified proteins were flash-frozen and stored in small aliquots at -80°C. 
 
Expression and purification of PABPC1 
Full length His-PABPC1 and His-PABPC1 (1-190) were expressed and purified from E. coli 
BL21 (DE3) using plasmids pQE80L-PABPC1 and pQE80L-PABPC1 (1-190). Plasmid 
6 
 
pQE80L-PABPC1 for the expression of PABPC1 with an N-terminal hexahistidine tag was 
generated by reverse-transcriptase PCR of a full length cDNA using total RNA from 
HEK293 cells as a template. 5’ BamHI and 3’ SalI restriction sites were added, which 
facilitated cloning of the PCR product into the corresponding restriction sites of plasmid 
pQE80L (Qiagen). Plasmid pQE80L-PABPC1 (1-190) was generated using inverse PCR 
and subsequent ligation of the linear product. 
After transformation of E. coli BL21 (DE3) with plasmid pQE80L-PABPC1 or pQE80L-
PABPC1(1-190), cells were grown in 1 L LB medium at 37°C until the OD600 was between 
0.7-0.8. After addition of IPTG (final concentration of 0.2 mM), cultures were incubated 
for 16h at 18°C and cells were harvested by centrifugation. The cell pellet was 
resuspended in 5 mL buffer HA and lysed by sonication. The soluble lysate was isolated 
by centrifugation and then loaded on a HisTrap FF pre-packed column (GE) equilibrated 
with buffer HA. After washing the unbound fraction, proteins were eluted (1 mL 
fractions) using buffer HB. Peak fractions were pooled and concentrated using a Vivaspin 
column (Sartorius) and further purified by size-exclusion chromatography (HiPrep 16/60 
Sephacryl S-200 HR, GE Healthcare) using buffer GF and collecting 2 mL fractions. Peak 
fractions were pooled and concentrated as described above. Protein concentrations were 
determined using the Protein Assay Reagent (Bio-Rad).  Purified proteins were stored in 
small aliquots at -80°C and confirmed to be free of ribonuclease activity. 
 
Enzyme assays 
For quantitative fluorescence-based assays using short poly(A) tails, reactions (50 µl) 
were essentially carried out as described before [29]. Briefly, reactions contained 0.2 µM 
enzyme, 1.0 µM substrate (Flc-CCUUUCCAAAAAAAAA, Eurogentec), 20 mM Tris-HCl pH 
7.9, 50 mM NaCl, 2 mM MgCl2, 10% glycerol, 1 mM β-mercaptoethanol. After incubation 
at 30°C for the indicated times, aliquots (5 µl) were taken and reactions were stopped 
by addition of an equal volume of DNA probe mix (1.0% SDS, 3 µM DNA probe, TAMRA-
TTTTTTTTTGGAAAGG, Eurogentec). After an overnight incubation in the dark, the 
fluorescence was measured using a Biotek Synergy HT plate reader. Fluorescence was 
measured at 25°C using the 485±20 nm and 528±20 nm filters for excitation and 
emission, respectively. 
 
For gel-based assays using (A)20 or (A)50 RNA substrates, standard reactions (25 µl) 
contained 100 nM enzyme, 20 mM Tris-HCl pH 7.9, 50 mM NaCl, 2 mM MgCl2, 10% 
glycerol, 1 mM β-mercaptoethanol and 0.2 µM 5’-Flc-labelled RNA substrate (Sigma-
Genosys) in nuclease-free water. Reactions were incubated at 30°C and aliquots (3.5 µl) 
were taken at the following time points: 0, 5, 10, 20, 30, 40 and 60 min. RNA loading 
buffer (1.0 µl) was added and samples heated for 3-5 min at 85°C. 
Reaction products were analysed by denaturing 20% polyacrylamide gel electrophoresis. 
Gels (acrylamide:bisacrylamide=19:1/50% urea, 1 TBE) were pre-run in 1 TBE at 
300 V for 30 min before loading samples (3.0 µl). After running the gels (20-25 min at 
300 V), reaction products were visualised by epi-fluorescence using a Fujifilm LAS-4000 
instrument equipped with an epi-blue illuminator. Gel images were analysed using 
ImageJ (https://imagej.nih.gov/ij/) using the Multiplot/ROI Manager function and 
densitometry plots were prepared using GraphPad Prism. 
 
To prepare PABPC1-poly(A) substrates, full length PABPC1 and a PABPC1 fragment 
encompassing RRM1 and RRM2 (amino acids 1-190) were used. PABPC1-poly(A)20 
substrates were prepared by incubating a 6-fold excess of full length PABPC1 or an 
8-fold excess of PABPC1 RRM1-RRM2 (amino acids 1-190) with poly(A)20 RNA for 15 min 
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at room temperature (20 mM Tris-HCl pH 7.9, 50 mM NaCl, 2 mM MgCl2, 10% glycerol, 1 
mM β-mercaptoethanol and 0.2 µM 5’-Flc-labelled poly(A)20 RNA substrate in nuclease-
free water) prior to the addition of enzyme.  
 
Computational analysis of protein structure 
To model the P131L amino acid substitution of CNOT9, the structure of a CNOT1-CNOT9 
complex (PDB accession number 4CRV) was used [15]. Pro-131 was substituted with five 
leucine rotamers with the highest probabilities (accumulated probability 0.994) according 
to the Dunbrack rotamer library and clashes and contacts with neighbouring atoms were 
then identified [30]. Subsequently, the structure was minimised to accommodate the 
substituted rotamer. The UCSF Chimera package was used for structure visualisation and 
analysis [31]. For energy minimisation, Molecular Modeling Toolkit routines and Amber 
parameters were used [32, 33]. 
 
Differential scanning fluorimetry 
Plasmid pQE80L-TEV-CNOT9 was made by inserting a codon-optimised CNOT9 cDNA 
(amino acids 33-283; using a 5’ BamHI and a 3’ SalI restriction site) into a modified 
pQE80L vector containing a TEV protease site following the N-terminal His-tag. The 
P131L variant of CNOT9 was generated by site-directed mutagenesis using a modified 
Quikchange protocol (Agilent). Proteins were expressed in E. coli BL21 (DE3) and 
purified using immobilised metal-affinity chromatography as described above. 
Differential scanning fluorimetry (thermal stability assay) was carried out using an 
Agilent MX3005p instrument and the fluorescent dye SYPRO Orange (5000 in DMSO, 
ThermoFisher Scientific) [34]. Standard assays (20 µl) contained: 2.5-10 µM purified 
CNOT9 or the P131L variant, 20 mM Tris-HCl pH 7.8, 500 mM NaCl, 10% glycerol, 1 mM 
β-mercaptoethanol, 5x SYPRO Orange dye. Reactions were performed in PCR-grade 96-
well thin-wall plates. After sealing with optical-grade lids, reactions were collected at the 
bottom of the wells by centrifugation. Fluorescence scanning was carried out using a 
temperature gradient from 25°C to 95°C at 1°C per minute using the FAM (492 nm) 
filter for excitation and the ROX (610 nm) filter for detection. Each experiment contained 
three technical replicates. Data was acquired using MxPro QPCR software (Agilent), and 




Reconstitution of the central module of the human Ccr4-Not complex 
To understand the biochemical mechanism of deadenylation by the human Ccr4-Not 
complex, we recently reported the reconstitution of a trimeric nuclease module 
composed of human BTG2-Caf1-Ccr4 [27]. To begin to investigate the contribution of 
the non-catalytic subunits of Ccr4-Not, we aimed to expand the nuclease module by 
including the central region of CNOT1 encompassing the MIF4G and DUF3819 domains 
(also known as the middle region CNOT1M [15]) and the CNOT9 subunit (Figure 1A, 1B).  
To this end, we explored various strategies. Co-expression of all five proteins in 
Escherichia coli resulted in a mixture of sub-complexes that were difficult to separate 
and relatively poor yields. Instead, separate expression and purification of the nuclease 
module and a CNOT1M-CNOT9 dimer, followed by reconstitution of the pentameric 
complex resulted in a robust procedure (Figure 1C). Thus, the components of the 
nuclease module, BTG2, Caf1 and Ccr4, were co-expressed as described before [27] 
except for the use of Ccr4 tagged with a Twin-Step tag (Figure 1D). In parallel, the 
CNOT1M-CNOT9 dimer was obtained by co-expression of His-tagged CNOT1 (amino 
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acids 1093-1595) and CNOT9 (amino acids 33-285) in bacterial cells followed by 
purification of the dimeric complex using immobilised metal-affinity chromatography 
(Figure 1D). The pentameric BTG2-Caf1-Ccr4-CNOT1-CNOT9 complex was then 
reconstituted by mixing the CNOT1M-CNOT9 dimer and the trimeric BTG2-Caf1-Ccr4 
nuclease module, following by a second round of Strep-affinity purification (Figure 1D). 
We termed this complex the central module reflecting the fact that this complex 
represents the proteins bound to the central region of CNOT1 encompassing the MIF4G 
and DUF3819 domains. 
 
CNOT1 (MIF4G-DUF3819) and CNOT9 stimulate deadenylation by the nuclease 
module 
As a first step to evaluate the contribution of the CNOT1 central region and the CNOT9 
subunit on the activity of the nuclease module, the activity of the complex was 
determined using a quantitative fluorescence-based assay [29]. In parallel, 
deadenylation by the nuclease module, Caf1 and the Caf1-BTG2 dimer was also 
determined. Analysis by SDS-PAGE showed that the protein samples contained similar 
amounts of the Caf1 subunit (Figure 2A). We then measured the activities of equimolar 
amounts of Caf1 and Caf1-containing complexes using a synthetic 16-mer 
oligonucleotide containing nine terminal adenosine residues as a substrate. In these 
assays, it was apparent that the activity of the central module was consistently higher 
than that of the nuclease module indicating that the CNOT1 central domain and CNOT9 
stimulate the activity of the nuclease module. Moreover, we confirmed our previous 
observations that the nuclease module has increased activity as compared to the BTG2-
Caf1 dimer, which in turn displays greater deadenylation compared to the isolated Caf1 
protein [27]. No activity was detected when catalytically inactive protein preparations 
were used, indicating that the observed activities were due to the catalytic activities of 
the purified proteins (Figure 2B). 
 
BTG2 stimulates the nuclease activity of Caf1 
Next, we assessed deadenylation in more detail using a 5’ fluorescein-labelled synthetic 
oligonucleotide containing 20 adenosine residues (Flc-A20) followed by product analysis 
using denaturing gel electrophoresis. Under conditions where the activity of Caf1 was 
barely measurable (Figure 3A), activity of the BTG2-Caf1 dimer was clearly detected 
(Figure 3B). This indicates that BTG2 stimulates the deadenylation activity of Caf1 
(p<0.05, Supplementary Figure S1) in agreement with our previous observation that 
BTG2 stimulates the ribonuclease activity of Caf1 [27].  
Next, we investigated degradation of poly(A) in the presence of cytoplasmic poly(A)-
binding protein PABPC1. We used a six-fold molar excess (protein:RNA) that resulted in 
binding of the majority of the poly(A) oligonucleotide substrate by PABPC1 
(Supplementary Figure S2). While the presence of PABPC1 did not affect the activity of 
Caf1 (compare Figure 3C and 3A), degradation of poly(A) by the BTG2-Caf1 dimer was 
increased in the presence of PABPC1 (compare Figure 3D and 3B; p<0.05, 
Supplementary Figure S1). This is in agreement with recent findings reported by Stupfler 
et al [35]. 
We then assessed deadenylation in the presence of a fragment of PABPC1 containing 
RRM1 and RRM2 (amino acid residues 1-190). Using an eight-fold molar excess 
(protein:RNA), virtually all poly(A) molecules were bound by one molecule of the PABPC1 
RRM1-RRM2 fragment as determined by a gel-shift assay (Supplementary Figure S2). As 
expected [35], these results mimicked those obtained with full length PABPC1: the 
presence of PABPC1 RRM1-RRM2 did not affect the activity of Caf1 (compare Figure 3E 
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and 3A), whereas deadenylation by BTG2-Caf1 was increased in the presence of the 
PABPC1 RRM1-RRM2 fragment (compare Figure 3F and 3B; p<0.05, Supplementary 
Figure S1). The activity of BTG2-Caf1 was stimulated by the PABPC1 RRM1-RRM2 
fragment to a similar extent as full length PABPC1 (compare Figure 3F and 3E, 
Supplementary Figure S1). Similar results were observed when a substrate containing 50 
adenosine residues was used (Supplementary Figure S3-S5). 
 
Deadenylation by the nuclease and central modules in the presence of poly(A)-
binding protein PABPC1 
When assessing deadenylation using a 5’ fluorescein-labelled synthetic oligonucleotide 
containing 20 adenosine residues (Flc-A20), the nuclease module displayed robust 
activity with fully deadenylated products detectable at later time points (Figure 4A). 
Compared to the nuclease module, faster deadenylation was observed in the presence of 
equimolar concentrations of the central module, with fully deadenylated products 
detected as the major product after 30 minutes (Figure 4B). These results confirm that 
the activity of the nuclease module is stimulated by the central module of CNOT1 and 
the CNOT9 subunit (p<0.05; Supplementary Figure S1). 
In the presence of PABPC1, stimulation of the activities of the nuclease and central 
modules was less evident. At earlier time points (5-20 min), deadenylation by the 
nuclease and central modules was further increased (Figure 4C, 4D). However, at later 
time points, a transient accumulation of partially deadenylated products was observed in 
the presence of PABPC1, which was not noticeable in the absence of PABPC1. This 
observation suggests a pause, which was observed after removal of approximately 12 
adenosine residues. A similar pattern of deadenylation was observed in the presence of a 
PABPC1 fragment encompassing RRM1 and RRM2 (Figure 4E and 4F) or when a 
substrate containing a 50 adenosine tail was used (Supplementary Figure S2-S4). When 
using this longer substrate, which can accommodate two molecules of PABPC1, two 
intermediate products were observed. 
Together, these results confirm that the central region of CNOT1 and the CNOT9 subunit 
contribute to the activity of the Ccr4-Not complex by stimulating the enzymatic activity 
of the nuclease module. In addition, these results indicate that PABPC1 can pose a 
transient block, which does not appear to involve the third and fourth RRM and the C-
terminal domain of PABPC1, because intermediary products are also observed in the 
presence of a PABPC1 fragment composed of RRM1 and RRM2.  
 
The thermal stability of CNOT9 is reduced by the lymphoma-associated P131L 
amino acid substitution 
Having established a positive role for the central fragment of CNOT1 and the CNOT9 
subunit in deadenylation, we investigated the impact of the amino acid substitution 
P131L of CNOT9. This amino acid alteration is frequently observed in melanoma tumours 
due to a recurrent somatic TC mutation. Residue Pro-131 is located in -helix 8 and in 
close proximity to -helix 5 (Figure 5A). Based on its location, substitution P131L is 
unlikely to directly disrupt interactions with the DUF3819 domain of CNOT1, or 
interactions mediated by the tryptophan-binding pockets of CNOT9, which are involved 
in interactions with GW182 and TTP [11, 15] (Figure 5A). However, computational 
analysis of the P131L amino acid substitution indicates multiple clashes with several 
backbone and side-chain atoms of residues Leu-82, Thr-83, Ala-84 and Ser-87 located in 
-helix 5 (Figure 5B). As a consequence, it is likely that structural changes are required 
to accommodate the P131L alteration. 
10 
 
Therefore, we tested the thermal stability of CNOT9 and the CNOT9 P131L variant by 
differential scanning fluorimetry (DSF). To this end, purified CNOT9 proteins were 
subjected to a temperature gradient and thermal stability (represented by the melting 
temperature Tm) of CNOT9 was determined by real-time measurement of fluorescence in 
the presence of the dye SYPRO Orange, which represents protein unfolding (Figure 5C). 
The experiments indicated that CNOT9 P131L showed a reduced Tm (Tm=-2.60±0.04C) 
(Figure 5C and 5D) consistent with decreased stability of CNOT9 due to structural 
rearrangements to accommodate the P131L amino acid alteration. 
 
The central module containing the melanoma-associated CNOT9 P131L variant 
supports deadenylation  
To test whether the reduced thermal stability of the P131L variant of CNOT9 affects the 
activity of the central module, we purified the central module containing the variant 
CNOT9 subunit. Expression and purification of the CNOT1-CNOT9 P131L complex in 
bacterial cells resulted in similar yields and purity compared to the wild type complex. In 
addition, reconstituted central modules containing CNOT9 P131L were readily obtained 
(Figure 6A). To test whether the P131L amino acid substitution of CNOT9 impacts on 
deadenylation by the central module, we evaluated the activity of equimolar amounts of 
the module containing wild type or P131L CNOT9. Comparison of the deadenylase 
activities of the complexes shows that the central module containing the CNOT9 P131L 
subunit displayed robust nuclease activity that is comparable to that of the wild type 
module (Figure 6B and 6C; Supplementary Figure S1).  
Together, these results indicate that the recurrent melanoma-associated amino acid 
substitution P131L does affect the thermal stability of CNOT9, but does not significantly 




The main findings reported here are: (i) we describe a procedure to reconstitute a 
pentameric sub-complex of Ccr4-Not, termed the central module, which is composed of 
the central region of CNOT1 containing the MIF4G and DUF3819 domains, the CNOT9 
subunit, and a trimeric nuclease module composed of BTG2, Caf1 and Ccr4; (ii) the 
pentameric central module of Ccr4-Not has a higher deadenylation activity as compared 
to the trimeric nuclease module revealing a new role for the central region of CNOT1 and 
CNOT9; and (iii) the melanoma-associated CNOT9 P131L variant supports deadenylation 
similar to the wild type subunit in the context of the pentameric central module of Ccr4-
Not. In addition, we also show that BTG2 stimulates the activity of Caf1, which is further 
enhanced in the presence of cytoplasmic poly(A)-binding protein PABPC1 in agreement 
with results reported by Stupfler et al. [35]. 
 
The role of the non-catalytic subunits  
The non-catalytic subunits of the Ccr4-Not complex are known to mediate interactions 
with RNA-binding factors that regulate RNA stability. In this regard, protein-protein 
interactions involving regulatory proteins and the CNOT1 and CNOT9 subunits are 
particularly well characterised. For example, the developmental regulator Nanos 
interacts with CNOT1 [8, 9], whereas Drosophila Bag-of-marbles and Roquin interact 
with the CNOT9 subunit [13, 36]. Moreover, GW182, a component of the miRNA-
repression complex, and the A/U-rich element binding protein TTP interact with both the 
CNOT1 and CNOT9 proteins [11-13, 15, 16, 36]. Interestingly, all known interactions 
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between regulatory factors and CNOT1 involve sequences outside the central region of 
CNOT1 studied here. 
A role for the non-catalytic subunits involved in stimulating the activity of the nuclease 
module was described for the S. pombe complex [26]. In this case, the reconstituted 
complex composed of eight subunits displays a significantly higher activity than the 
isolated nuclease module. Our findings presented here demonstrate that the central 
region of CNOT1 encompassing the MIF4G and DUF3819 domains together with CNOT9 
increase the activity of the human nuclease module. There are at least two possible 
mechanisms by which the complex of CNOT1 and CNOT9 may enhance the activity of the 
nuclease module. Firstly, the non-catalytic subunits may regulate the activity of the 
nuclease subunits via an allosteric mechanism and induce a conformation with higher 
activity. Alternatively, the non-catalytic subunits may interact with RNA, thereby 
enhancing the affinity for the substrate. Although CNOT9 can interact with nucleic acids 
[37], it is not obvious from the available structural information how this would lead to 
increased degradation of the poly(A) substrate used. Further structural information 
integrating available information of isolated modules is required to provide a rationale for 
the experimental observations presented here. 
 
The melanoma-associated CNOT9 P131L variant  
Exome sequencing of metastatic melanoma samples led to the identification of a variant 
CNOT9 subunit containing the P131L amino acid substitution [28]. This variant is found 
in a subset of melanoma cell lines and tumours and is caused by a TC transition 
induced by exposure to UV light. Typically, this mutation only affects one allele 
suggesting that both the P131L variant and the wild type protein are present in 
melanoma cells. Modelling the P131L amino acid change suggests that the substitution is 
unlikely to directly affect the tryptophan-binding pockets of CNOT9, which are involved 
in interactions with GW182 and TTP [11, 15, 16]. Moreover, while the amino acid change 
affects the structural stability of CNOT9 as determined by differential scanning 
fluorimetry, the central module containing the CNOT9 P131L subunit is able to support 
deadenylation comparable to the central module containing wild type CNOT9. Based on 
this observation, we propose that the P131L amino acid change may affect specific 
protein-protein interactions involving CNOT9, or result in reduced protein levels due to 
decreased cellular stability.  
 
Deadenylation in the presence of PABPC1  
BTG2 is a member of a small protein family that includes BTG1-4, TOB1 and TOB2 [38, 
39], which stimulate deadenylation and mRNA degradation [40-43]. Recently, it was 
demonstrated that BTG2 can enhance deadenylation by the isolated Caf1 protein in the 
presence of PABPC1 [35]. Although our results indicate that BTG2 can also increase the 
activity of Caf1 in the absence of PABPC1, a further stimulation of Caf1 activity is 
observed in the presence of PABPC1 or a fragment of PABPC1 containing the RRM1 and 
RRM2 domains in agreement with results previously reported by Stupfler et al [35]. 
However, stimulation of deadenylation by PABPC1 was less evident in the presence of 
the nuclease and central modules, which display a much increased activity as compared 
to the dimeric complex composed of BTG2 and Caf1. While degradation of poly(A) 
containing 20 residues by the nuclease and central modules was increased at early time 
points in the presence of PABPC1 or the fragment containing the first two RRM domains, 
a transient accumulation of intermediary products was observed at later time points. 
Interestingly, the length of the transiently accumulated product is about eight 
nucleotides, which corresponds to the number of nucleotides that interact with RRM1 and 
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RRM2 of PABPC1 [44]. This suggests that dissociation of PABPC1 is required for complete 
degradation of the substrate. When longer substrates were used that can accommodate 
the binding of two PABPC1 molecules, an additional intermediary product was observed 
(Supplementary Figure S3-S4). 
 
In summary, the work presented here reveals a role for central region of CNOT1 and the 
non-catalytic CNOT9 subunit in stimulating the activity of the nuclease module of the 
Ccr4-Not complex. Moreover, it demonstrated that the melanoma-associated CNOT9 
P131L variant retains the ability to be incorporated into the central module of the 




This work was supported by a University of Nottingham Vice-Chancellor’s Scholarship for 
Research Excellence (L.P.), the Biotechnology and Biological Sciences Research Council 
(BBSRC) Doctoral Training Programme at the University of Nottingham (B.H.), and a 
Faculty for the Future scholarship of the Schlumberger Foundation (B.A.). Emma Gunnell 
and Ingrid Dreveny are gratefully acknowledged for helpful discussions. 
 




The study was conceived by G.S.W. The experiments were designed by L.P. and G.S.W. 
L.P. carried out all experiments shown in Figures 1-6 and the supplementary material. 
B.H. constructed the pQE80L expression vector containing a TEV protease site and 
prepared several CNOT9 and CNOT9 P131L constructs for prokaryotic expression. B.A. 
modified the procedure for purification of the trimeric nuclease module using co-
expression of Strep-tagged Ccr4/CNOT6L, Caf1/CNOT7 and His-BTG2. Data was 
analysed by L.P. and G.S.W. The manuscript was prepared by L.P. and G.S.W. All 










Figure 1. Reconstitution of a Ccr4-Not central module composed of BTG2-Caf1-Ccr4-
CNOT1MIF4G-DUF3869-CNOT9. (A) Schematic diagram of the Ccr4-Not complex. Highlighted 
are the nuclease module (yellow), the BTG2 protein (blue) and the CNOT9 module 
(green). The location of the subunits is based on the structure of the Saccharomyces 
cerevisiae Ccr4-Not complex [45]. (B) Diagram of the subunit organisation in the Ccr4-
Not complex. Indicated are known domains involved in protein-protein interactions 
between subunits. The central region of CNOT1 (amino acids 1093-1595) encompasses 
the MIF4G and DUF3819 domains. (C) Overview of the purification strategy. (D) 
Purification of the nuclease module (left panel), the CNOT1-CNOT9 dimer (middle) and 
the reconstituted central module composed of BTG2, Caf1/CNOT7, Ccr4/CNOT6L, CNOT1 
(MIF4G-DUF3869) and CNOT9 (right). Purified protein complexes (5 µg) were subjected 






Figure 2. Deadenylation by the nuclease module is stimulated by the central region of 
CNOT1 and CNOT9. (A) Analysis of Caf1 and Caf1-containing complexes. Proteins were 
separated by 14% SDS-PAGE and visualised by Coomassie staining. M, Caf1 D40A 
mutant; DM (double mutant), complexes containing inactive nuclease subunits Caf1 
D40A/Ccr4 E240A. (B) Deadenylation by Caf1, the Caf1-BTG2 dimer, the nuclease 
module composed of BTG2, Caf1 and Ccr4, and the central module composed of BTG2, 
Caf1, Ccr4, the central region of CNOT1 and CNOT9. Reactions contained a synthetic 16-
mer oligonucleotide with nine terminal adenosine residues (1.0 µM) which were 
incubated with the indicated enzymes (200 nM) at 30C for the indicated time. 
Deadenylation was determined by measuring fluorescence as described previously [29]. 
Error bars indicate the standard error of the mean (n=4). * P<0.05; ** P<0.01, **** 
P<0.0001; black, nuclease compared to central module; blue, nuclease complex 
compared to Caf1-BTG2 complex; red, Caf1-BTG2 complex compared to Caf1. P values 







Figure 3. BTG2 stimulates the activity of Caf1. (A) Deadenylation of poly(A) by Caf1. (B) 
Deadenylation of poly(A) by the Caf1-BTG2 dimer. (C) Deadenylation of poly(A) in the 
presence of full length PABPC1 by Caf1. (D) Deadenylation of poly(A) in the presence of 
full length PABPC1 by the BTG2-Caf1 dimer. (E) Deadenylation of poly(A) in the presence 
of PABPC1 RRM1-RRM2 by Caf1. (F) Deadenylation of poly(A) in the presence of PABPC1 
RRM1-RRM2 by the BTG2-Caf1 dimer. Synthetic oligonucleotides (200 nM 5’Flc-(A)20) were 
incubated with the indicated enzymes (100 nM) at 30C and stopped at the indicated time 
points. Products were analysed by denaturing 50% urea/20% PAGE (left). Densitometric 






Figure 4. The central region of CNOT1 and CNOT9 enhance the activity of the nuclease 
module. (A) Deadenylation of poly(A) by the trimeric nuclease module. (B) 
Deadenylation of poly(A) by the pentameric central module. (C) Deadenylation of 
poly(A) in the presence of full length PABPC1 by the trimeric nuclease module. (D) 
Deadenylation of poly(A) in the presence of full length PABPC1 by the pentameric central 
module. (E) Deadenylation of poly(A) in the presence of PABPC1 RRM1-RRM2 by the 
trimeric nuclease module. (F) Deadenylation of poly(A) in the presence of PABPC1 RRM1-
RRM2 by the pentameric central module. Synthetic oligonucleotides (200 nM 5’Flc-(A)20) 
were incubated with the indicated enzymes (100 nM) at 30C and stopped at the 
indicated time points. Products were analysed by denaturing 50% urea/20% PAGE (left). 





Figure 5. Reduced thermal stability caused by the CNOT9 P131L amino acid 
substitution. (A) Overview of the CNOT9-CNOT1 (DUF3819) protein complex (PDB 4CRV) 
[15]. Indicated are CNOT9 (tan), the DUF3819 domain of CNOT1 (green), the position of 
Pro-131 of CNOT9 (part of -helix 8), the neighbouring -helix 5, and the two 
tryptophan binding pockets of CNOT9. (B) The Pro-131Leu amino acid substitution is 
predicted to result in multiple clashes with -helix 5. Indicated are -helix 8 (tan), 
including the position of Pro-131 (left) and the modelling of leucine rotamers (right), 
-helix 5 (blue), including amino acids that display multiple predicted clashes with 
leucine rotamers. (C) Differential scanning fluorimetry of CNOT9 and CNOT9 P131L. Wild 
type and CNOT9 P131L (5.0 µM) was incubated in the presence of SYPRO Orange dye 
and subjected to a temperature gradient from 25 to 95C (1 min/C). (D) Reduced 
thermal stability of CNOT9 P131L (grey) compared to wild type CNOT9 (black). 







Figure 6. The central module containing the CNOT9 P131L variant supports 
deadenylation. (A) Purification of pentameric core complexes containing wild type CNOT9 
and CNOT9 P131L. Purified protein complexes (5 µg) were subjected to 14% SDS-PAGE 
and stained with Coomassie. (B) Deadenylation of poly(A) by the pentameric core 
complex containing wild type CNOT9. (C) Deadenylation of poly(A) by the pentameric 
core complex containing the melanoma-associated CNOT9 P131L variant. Substrate 
(200 nM 5’Flc-(A)20) was incubated with the indicated enzymes (100 nM) at 30C and 
stopped at the indicated time points. Products were analysed by denaturing 50% 
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